In other countries
The same active substances on other registers, the same brand first.
- VyvanseNew Zealand · Cap 50 mgSame brand
- VyvanseNew Zealand · Cap 30 mgSame brand
- VyvanseNew Zealand · Cap 70 mgSame brand
- VyvanseSaudi Arabia · Patheon Pharmaceuticals Inc.Same brand
- VYVANSE CAPSULES 20 mgSingapore · 20.0 mg · capsule · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same brand
- VYVANSE CAPSULES 30 mgSingapore · 30.0 mg · capsule · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same brand
- VYVANSE CAPSULES 40 mgSingapore · 40.0 mg · capsule · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same brand
- VyvanseUnited States · 10MG, 20MG, 30MG … · capsule · Takeda Pharms USASame brand
- VyvanseUnited States · 10MG, 20MG, 30MG … · tablet, chewable · Takeda Pharms USASame brand
- MinalixItaly · Capsula rigida · Farmitalia Industria Chimico Farmaceutica S.R.L.Same form
- Elvanse 30 mg, harde capsulesNetherlands · Capsule, hard · Euro Registratie Collectief B.V.Same form
- Lisdexamfetamine CF 20 mg, harde capsulesNetherlands · Capsule, hard · Centrafarm B.V.Same form
- Lisdexamfetamine CF 30 mg, harde capsulesNetherlands · Capsule, hard · Centrafarm B.V.Same form
- Lisdexamfetamine DimesylateUnited States · 10MG, 20MG, 30MG … · capsule · AmnealSame form
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Lisdexamfetamine dimesylate
- Strength
- 60 MG
- Dosage form
- Capsule
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 14 Apr 2010
- Registration
- DIN 02347172
- Marketing authorisation holder
- Takeda Canada INC
- ATC code
- N06BA12
- Group
- Nervous system
- Supply
- CONTROLLED DRUGS (CDSA I)